NICE ‘ok’ for Bayer’s Xarelto

18th October 2019 Uncategorised 0

The drug is an anticoagulant that targets Factor Xa, approved to prevent atherothrombotic events in coronary artery disease.

More: NICE ‘ok’ for Bayer’s Xarelto
Source: News